Status:
COMPLETED
The Clinical Study Aims to Assess the Quality of Donor Livers Using Hyperspectral Imaging.
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Conditions:
Liver Transplantation
Hyperspectral Imaging
Eligibility:
All Genders
18-65 years
Brief Summary
Based on hyperspectral imaging equipment, this project collected hyperspectral imaging data of donor livers, analyzed various parameters, investigated the detection capability of hyperspectral imaging...
Detailed Description
Hyperspectral imaging (HSI) is an advanced optical technology that combines spectroscopy and imaging, providing a non-destructive approach for clinical diagnosis. In recent years, hyperspectral imagin...
Eligibility Criteria
Inclusion
- Recipients ranged in age from 18 to 65
- Donor age ≥ 18 years
Exclusion
- Recipients are younger than 18 years or older than 65 years
- Donor younger than 18 years
- Secondary liver transplantation.
- Multiple organ transplantation.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06608667
Start Date
June 1 2022
End Date
June 30 2024
Last Update
September 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital Xian Jiaotong University
Xi'an, Shaanxi, China, 710061